PT  - JOURNAL ARTICLE
AU  - Lussier, Alexandre A.
AU  - Hawrilenko, Matt
AU  - Wang, Min-Jung
AU  - Choi, Karmel W.
AU  - Cerutti, Janine
AU  - Zhu, Yiwen
AU - Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
AU  - Dunn, Erin C.
TI  - Genetic susceptibility for major depressive disorder associates with trajectories of depressive symptoms across childhood and adolescence
AID  - 10.1101/2020.03.02.19007088
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.02.19007088
4099  - http://medrxiv.org/content/early/2020/08/28/2020.03.02.19007088.short
4100  - http://medrxiv.org/content/early/2020/08/28/2020.03.02.19007088.full
AB  - Background Early-onset depression during childhood and adolescence is associated with a worse course of illness and outcome than adult onset. However, the genetic factors that influence risk for early-onset depression remain mostly unknown. Using data collected over 13 years, we examined whether polygenic risk scores (PRS) that capture genetic risk for depression were associated with depression trajectories assessed from childhood to adolescence.Methods Data came from the Avon Longitudinal Study of Parents and Children, a prospective, longitudinal birth cohort (analytic sample=7,308 youth). We analyzed the relationship between genetic susceptibility to depression and three time-dependent measures of depressive symptoms trajectories spanning 4 to 16.5 years of age (class, onset, and cumulative burden). Trajectories were constructed using a growth mixture model with structured residuals. PRS were generated from the summary statistics of a genome-wide association study of depression risk using data from the Psychiatric Genomics Consortium, UK Biobank, and 23andme, Inc. We used MAGMA to identify gene-level associations with these measures.Results Youth were classified into 6 classes of depressive symptom trajectories: high/renitent (26.5% of youth), high/reversing (5.8%), childhood decrease (6.1%), late childhood peak (3%), adolescent spike (2.5%), and minimal symptoms (56.1%). PRS discriminated between youth in the late childhood peak, high/reversing, and high/renitent classes compared to the minimal symptoms and childhood decrease classes. No significant associations were detected at the gene level.Conclusions This study highlights differences in polygenic loading for depressive symptoms across childhood and adolescence, particularly among youths with high symptoms in early adolescence, regardless of age-independent patterns.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the National Institute of Mental Health of the National Institutes of Health under Award Numbers K01MH102403 and R01MH113930 (Dunn), and T32MH017119 (Choi). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council and the Wellcome Trust (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. This publication is the work of the authors who will serve as guarantors for the contents of this paper.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesThe data for the present study are available through the Avon Longitudinal Study of Parents and Children (ALSPAC). http://www.bristol.ac.uk/alspac/